Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
AHA says aortic stenosis is undertreated and underdiagnosed | High copays lower PAH drug adherence | New ASE app
Tuesday, November 15, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Higher copayments lowered adherence for pulmonary artery hypertension medications 

The more a patient has to pay for medications, the less likely they are to take them. This was the finding of a new study showing how copayments may be a barrier to drugs to treat pulmonary arterial hypertension.

READ MORE >
Pulmonary hypertension (PAH) is usually treated with medication, but the more a patient has to pay for medications, the less likely they are to take them and become noncompliant. This was the finding of a new study showing how copayments may be a barrier to patients taking prostanoids and combination therapy for PAH.
Share on Twitter Share on Facebook Share on Linkedin

Higher copayments lowered adherence for pulmonary artery hypertension medications 

Share on Twitter Share on Facebook Share on Linkedin
Pulmonary hypertension (PAH) is usually treated with medication, but the more a patient has to pay for medications, the less likely they are to take them and become noncompliant. This was the finding of a new study showing how copayments may be a barrier to patients taking prostanoids and combination therapy for PAH.
The more a patient has to pay for medications, the less likely they are to take them. This was the finding of a new study showing how copayments may be a barrier to drugs to treat pulmonary arterial hypertension.
READ MORE >

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

READ MORE >
Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Share on Twitter Share on Facebook Share on Linkedin
Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.
Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 
READ MORE >

American Society of Echocardiography releases new EchoGuide clinical calculator app

The ASE launched its new, interactive EchoGuide mobile and web application, and already has about 15,000 downloads.

READ MORE >
The American Society of Echocardiography (ASE) launched its new, interactive EchoGuide mobile and web application for healthcare professionals last week, and the society said it already has about 15,000 downloads.
Share on Twitter Share on Facebook Share on Linkedin

American Society of Echocardiography releases new EchoGuide clinical calculator app

Share on Twitter Share on Facebook Share on Linkedin
The American Society of Echocardiography (ASE) launched its new, interactive EchoGuide mobile and web application for healthcare professionals last week, and the society said it already has about 15,000 downloads.
The ASE launched its new, interactive EchoGuide mobile and web application, and already has about 15,000 downloads.
READ MORE >

In Case You Missed It

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

READ MORE >
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Key takeaways from AHA 2022

Share on Twitter Share on Facebook Share on Linkedin
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22
Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.
READ MORE >

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 

READ MORE >
U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.
Share on Twitter Share on Facebook Share on Linkedin

FDA Commissioner Robert Califf calls on cardiology to address health inequities and combat misinformation

Share on Twitter Share on Facebook Share on Linkedin
U.S. Food and Drug Administration Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association (AHA) last week about the need for doctors and health systems to step up to address two major problems - misinformation and health disparities.
FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 
READ MORE >

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

READ MORE >
Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022
Share on Twitter Share on Facebook Share on Linkedin

Links to the American Heart Association 2022 late-breaking studies

Share on Twitter Share on Facebook Share on Linkedin
Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022
The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.
READ MORE >

Around the Web

RSNA primes 2022 conference attendees for virtual participation, technical exhibits

With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.

READ MORE >
RSNA connections
Share on Twitter Share on Facebook Share on Linkedin

RSNA primes 2022 conference attendees for virtual participation, technical exhibits

Share on Twitter Share on Facebook Share on Linkedin
RSNA connections
With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.
READ MORE >

Upped imaging utilization seems to follow ED clinicians who aren’t physicians

Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.

READ MORE >
emergency.jpg
Share on Twitter Share on Facebook Share on Linkedin

Upped imaging utilization seems to follow ED clinicians who aren’t physicians

Share on Twitter Share on Facebook Share on Linkedin
emergency.jpg
Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.
READ MORE >

New study may give insight into the neurologic dysfunction of some long-COVID patients

Vessel wall imaging—an MRI technique that offers high resolution images of the vessel wall—may hold clues as to the mechanisms by which COVID infections continue to cause neurologic symptoms after initial recovery in some patients.  

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New study may give insight into the neurologic dysfunction of some long-COVID patients

Share on Twitter Share on Facebook Share on Linkedin
Vessel wall imaging—an MRI technique that offers high resolution images of the vessel wall—may hold clues as to the mechanisms by which COVID infections continue to cause neurologic symptoms after initial recovery in some patients.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme